Haematological cancer: Brentuximab effective in untreated Hodgkin lymphoma

Haematological cancer: Brentuximab effective in untreated Hodgkin lymphomaHaematological cancer: Brentuximab effective in untreated Hodgkin lymphoma, Published online: 28 December 2017; doi:10.1038/nrclinonc.2017.209Haematological cancer: Brentuximab effective in untreated Hodgkin lymphoma

Source: Nature Clinical Practice Oncology - December 28, 2017 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research